Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Medical Kiwi signs exclusive deal with CBD distributor

South-Island based medicinal cannabis company Medical Kiwi has signed an exclusive distribution deal with United Kingdom CBD product distributor Vitality CBD.

Established in December 2018, Medical Kiwi is a medicinal research and nutraceutical company, created to take advantage of the global opportunity that medicinal cannabis represents. They are the only New Zealand company to sign a distribution agreement with Vitality CDB Ltd.

The exclusive deal with the UK company will allow Medical Kiwi to import and sell CBD products as soon as the Medicinal Cannabis Scheme is operational in the first quarter of 2020.
Medical Kiwi Board Chair Aldo Miccio says the deal is an exciting step towards the company’s plans to provide New Zealanders with affordable access to safe, high-quality medicinal and neutraceutical cannabis products.

“Medical Kiwi will sell Vitality CBD’s full range of CBD products, including sprays, drops, skin cream, balms, and e-liquids. The range is currently sold across the UK including in Boots stores, Tesco supermarkets, pharmacies and health stores.”

The CBD products contain cannabidiols derived from cannabis, and are 0% THC, meaning they have no psychoactive properties.

“This agreement is part of Medical Kiwi’s strategy to import and distribute pre-branded medicinal and nutraceutical products, to create accessibility via imported products until our own Medical Kiwi products are available," says Miccio.

Last month the company announced its plans for the build of a state-of-the-art research and development facility in Brightwater, Tasman. They have been granted a licence by the Ministry of Health to cultivate medicinal cannabis, enabling the company to establish a cannabis breeding programme for research.

The build of the 8,000 –10,000 m2 facility is set to start in late 2020. Its design aligns environmental responsibility with commercial objectives, including technology to ensure agricultural and commercial practices are sustainable.

Miccio says the facility and resulting products will have significant economic benefits for the Nelson Tasman region and for New Zealand. “Our research will focus on the development of medicinal cannabis products, with a particular focus on the optimum growth conditions,” he says.

Until the plant is operational, Medical Kiwi will advance their vision of making medicinal cannabis products available to New Zealanders by selling imported product as soon as the law allows.
“Our business model is for Medical Kiwi’s New Zealand-made and imported products to cost significantly less than current prescription prices,” says Miccio. “Once the Medicinal Cannabis Scheme is in place, we will be able to share a lot more about what that means.”

Miccio says Patrick Gower’s documentary On Weed, debuting on TV3 on 11 September, demonstrated some of the major and important benefits of medicinal cannabis.

The documentary rightly pointed out that the medicinal cannabis industry in New Zealand is ready and waiting. Medical Kiwi is poised to make our vision – that everyone who could benefit from medicinal cannabis can safely access effective, high-quality, affordable products – into reality.”

Investment opportunity
Last month, Medical Kiwi Ltd released an Investment Memorandum for private professional investors, offering shares in the company in two series.

“We raised $1 million in seed funding from both private investors and investors from the smart money sector in the US, who all recognise the value of New Zealand-origin medicinal cannabis products,” says Miccio. “We are now offering a new share issue to raise $7.5 million, providing investors with an opportunity to invest early in Series A. A Series B share offer will follow later this year.”

The full scope of Medical Kiwi’s operations from 2020 onwards will cover research and development and cultivation, extraction, manufacturing, supply and distribution, and marketing of medicinal and nutraceutical cannabis products.

More information can be found on the Medical Kiwi website. www.medicalkiwi.com and at www.facebook.com/MedicalKiwiNZ/. You can find out more about Vitality CBD at https://vitalitycbd.co.uk/

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Science Media Centre: Funding For R&D In New Zealand – Expert Reaction

Research, Science and Innovation Minister Dr Megan Woods has today announced $401.3 million funding for research and development through Budget 2020 and the COVID Response and Recovery Fund. The fund includes $150 million for an R&D loan scheme, ... More>>

ALSO:

Maritime NZ: NZ Joins Global Initiative Keeping Ports Open And Freight Moving

New Zealand has joined an international port authorities’ global initiative for safe and efficient movement of goods and shipping during the COVID-19 crisis. World-wide, 56 port authorities have agreed how they will work together facilitating maritime ... More>>

ALSO:

National: National Backs Businesses With $10k JobStart

National will provide a $10,000 cash payment to businesses that hire additional staff as part of our commitment to keeping New Zealanders in jobs, National Party Leader Todd Muller and Finance spokesperson Paul Goldsmith have announced. Our JobStart ... More>>

ALSO:

DIY Law: Government Exempts Some Home Improvements From Costly Consents

Homeowners, builders and DIYers will soon have an easier time making basic home improvements as the Government scraps the need for consents for low-risk building work such as sleep-outs, sheds and carports – allowing the construction sector ... More>>

ALSO:

Media Awards: The New Zealand Herald Named Newspaper Of The Year, Website Of The Year At Voyager Media Awards

The New Zealand Herald has been labelled a “powerhouse news operation” as it claims the two biggest prizes – Newspaper of the Year and Website of the Year – along with many individual awards at the 2020 Voyager Media Awards Website of the ... More>>

ALSO:

ASB Bank: ASB Takes The Lead Again With New Low Home Loan Interest Rate

ASB has moved again to support its customers, cutting a number of home loan rates, including the two-year special rate to a new low of 2.69% p.a. Craig Sims, ASB executive general manager Retail Banking says the reduced rate will be welcome news for many ... More>>

ALSO:

Nathan Hoturoa Gray: The Problems With Testing And Case Statistics For Covid-19

To begin to understand disease transmission in a country requires adequate testing of your population with properly vetted, accurate tests. As the world struggles to find what 'adequate percentage' of the population is necessary, (estimates predict ... More>>

ALSO:

RNZ: Fletcher Building To Lay Off 1000 Staff In New Zealand

The construction company will cut around 10 percent of its workforce as it struggles with the fallout from Covid-19. More>>

ALSO:

Can Pay, Won't Pay: Cashflow Moves Urged

Government Ministers are asking significant private enterprises to adopt prompt payment practices in line with the state sector, as a way to improve cashflow for small businesses. More>>

ALSO:

Gordon Campbell: On Why We Should Legally Protect The Right To Work From Home

For understandable reasons, the media messaging around Level Two has been all about “freedom” and “celebration”, but this is not necessarily going to be a universal experience. When it comes to workplace relations, Level Two is just as likely to ... More>>

ALSO:



New Zealand Government: Supporting Kiwi Businesses To Resolve Rent Disputes

The Government will legislate to ensure businesses that suffered as a result of the COVID-19 response will get help to resolve disputes over commercial rent issues, Justice Minister Andrew Little announced today. More>>

ALSO:


Science Media Centre: Understanding 5G Concerns – Expert Q&A


Recent attacks on cell phone towers have brought concerns over the rollout of 5G technology into sharp relief.
While scientific research has consistently shown that the technology does not adversely affect human health, public concerns about its impact have spread around the world, fueled in part by growing misinformation online. The SMC asked experts to comment... More>>

ALSO:


Trade: Record Monthly Surplus As Imports Dive

Imports in April 2020 had their biggest fall since October 2009, resulting in a monthly trade surplus of $1.3 billion, Stats NZ said today. “This is the largest monthly trade surplus on record and the annual goods trade deficit is the lowest ... More>>

ALSO:


Media Blues: Stuff Chief Executive Buys Company For $1

Stuff chief executive Sinead Boucher has purchased Stuff from its Australian owners Nine Entertainment for $1.
The chief executive was returning the company to New Zealand ownership, with the sale is expected to be completed by 31 May.
"Our plan is to transition the ownership of Stuff to give staff a direct stake in the business as shareholders," Boucher said in a statement.... More>>

ALSO:

RNZ: Bar Reopening Night 'much, Much Quieter'

Pubs and bars are reporting a sluggish first day back after the lockdown, with the fear of going out, or perhaps the joy of staying home, thought to be a reason for the low numbers. More>>

ALSO:

Stats NZ: New Zealand’s Population Passes 5 Million

New Zealand's resident population provisionally reached 5 million in March 2020, Stats NZ said today. More>>

NIWA: Seven Weeks Of Clearing The Air Provides Huge Benefits: Scientist

Seven weeks of lockdown has provided evidence of how pollution can vanish overnight with benefits for the environment and individuals, says NIWA air quality scientist Dr Ian Longley. Dr Longley has been monitoring air quality in Auckland, Wellington ... More>>

ALSO:

Government: Milestone In Cash Flow Support To SMEs

A significant package of tax reforms will be pushed through all stages in Parliament today to throw a cash flow lifeline to small businesses. More>>

ALSO: